DNA Operating Expenses
$380.29MTTM · USD
Period ending:
DNA FY Operating ExpensesUSD
$2.48B$0.00
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
DNA operating expenses history
Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | Operating Expenses (USD) |
|---|---|
| 453,912,000 | |
| 748,251,000 | |
| 1,061,856,000 | |
| 2,482,442,000 | |
| 2,012,614,000 | |
| 198,073,000 | |
| 125,782,000 |
Compare operating expenses
All DNA financial metrics · DNA stock overview · How to interpret financial metrics
